These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35533906)

  • 1. PAX9 reactivation by inhibiting DNA methyltransferase triggers antitumor effect in oral squamous cell carcinoma.
    Bhol CS; Mishra SR; Patil S; Sahu SK; Kirtana R; Manna S; Shanmugam MK; Sethi G; Patra SK; Bhutia SK
    Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166428. PubMed ID: 35533906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pax9 mediated cell survival in oral squamous carcinoma cell enhanced by c-myb.
    Lee JC; Sharma M; Lee YH; Lee NH; Kim SY; Yun JS; Nam SY; Hwang PH; Jhee EC; Yi HK
    Cell Biochem Funct; 2008 Dec; 26(8):892-9. PubMed ID: 18979497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
    Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
    Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX9 regulates squamous cell differentiation and carcinogenesis in the oro-oesophageal epithelium.
    Xiong Z; Ren S; Chen H; Liu Y; Huang C; Zhang YL; Odera JO; Chen T; Kist R; Peters H; Garman K; Sun Z; Chen X
    J Pathol; 2018 Feb; 244(2):164-175. PubMed ID: 29055049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.
    Lee CH; Pan KL; Tang YC; Tsai MH; Cheng AJ; Shen MY; Cheng YM; Huang TT; Lin P
    Oncotarget; 2015 Sep; 6(28):25188-201. PubMed ID: 26317789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
    Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
    J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2/HO-1 Alleviates Disulfiram/Copper-Induced Ferroptosis in Oral Squamous Cell Carcinoma.
    Zhao Y; Zhu S
    Biochem Genet; 2024 Feb; 62(1):144-155. PubMed ID: 37286868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
    Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
    Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icaritin Reduces Oral Squamous Cell Carcinoma Progression via the Inhibition of STAT3 Signaling.
    Yang JG; Lu R; Ye XJ; Zhang J; Tan YQ; Zhou G
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite effects of arsenic trioxide on the Nrf2 pathway in oral squamous cell carcinoma in vitro and in vivo.
    Zhang X; Su Y; Zhang M; Sun Z
    Cancer Lett; 2012 May; 318(1):93-8. PubMed ID: 22155346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
    Zhang J; Ling T; Wu H; Wang K
    J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m
    Luo R; Xie L; Lin Y; Shao J; Lin Z
    Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36004481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palbociclib induces DNA damage and inhibits DNA repair to induce cellular senescence and apoptosis in oral squamous cell carcinoma.
    Wang TH; Chen CC; Leu YL; Lee YS; Lian JH; Hsieh HL; Chen CY
    J Formos Med Assoc; 2021 Sep; 120(9):1695-1705. PubMed ID: 33342707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
    Liu S; Gao W; Lu Y; Zhou Q; Su R; Hasegawa T; Du J; Li M
    Int J Biol Sci; 2022; 18(2):491-506. PubMed ID: 35002505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringenin induces endoplasmic reticulum stress-mediated cell apoptosis and autophagy in human oral squamous cell carcinoma cells.
    Liu JF; Chang TM; Chen PH; Lin JS; Tsai YJ; Wu HM; Lee CJ
    J Food Biochem; 2022 Nov; 46(11):e14221. PubMed ID: 35596593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioral Squamous Cell Carcinoma Effects of Carvacrol via Inhibiting Inflammation, Proliferation, and Migration Related to Nrf2/Keap1 Pathway.
    Liu H; Xu X; Wu R; Bi L; Zhang C; Chen H; Yang Y
    Biomed Res Int; 2021; 2021():6616547. PubMed ID: 34212035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
    Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
    BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.